Alpha Crest Capital Management LLC Bluebird Bio, Inc. Transaction History

Alpha Crest Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$4.07 - $10.6 $440,166 - $1.15 Million	-108,149 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$8.96 - $16.31 $804,177 - $1.46 Million	89,752 Added 487.86%	108,149 $1.08 Million
Q3 2021 Nov 10, 2021	BUY	$11.24 - $21.0 $206,782 - $386,337	18,397 New	18,397 $352,000
Q2 2021 Aug 12, 2021	SELL	$18.04 - $22.09 $309,548 - $379,042	-17,159 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$16.59 - $33.89 $186,471 - $380,923	11,240 Added 189.9%	17,159 $517,000
Q4 2020 Feb 12, 2021	SELL	$27.5 - $37.92 $106,315 - $146,598	-3,866 Reduced 39.51%	5,919 $256,000
Q3 2020 Nov 12, 2020	BUY	$34.44 - $43.75 $209,601 - $266,262	6,086 Added 164.53%	9,785 $528,000
Q2 2020 Aug 12, 2020	SELL	$27.12 - $45.97 $22,753 - $38,568	-839 Reduced 18.49%	3,699 $226,000
Q1 2020 May 13, 2020	BUY	$26.16 - $63.5 $118,714 - $288,163	4,538 New	4,538 $209,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $23.1M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.